Censo Biotechnologies
Drug Discovery with Human Cells.
Launch date
Employees
Market cap
-
Enterprise valuation
€6—9m (Dealroom.co estimates Oct 2018.)
Company register number SC348293
Roslin Scotland (HQ)
Financials
Estimates*
| EUR | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | - | (15 %) | (68 %) | 114 % | 3 % | 2 % |
| EBITDA | <1m | <1m | (<1m) | (<1m) | (<1m) | (<1m) |
| % EBITDA margin | 4 % | 9 % | (157 %) | (38 %) | (7 %) | (6 %) |
| Profit | - | - | (<1m) | (<1m) | (<1m) | <1m |
| % profit margin | - | - | (143 %) | (27 %) | (14 %) | 2 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
£700k | Grant | ||
* | £1.3m | Early VC | |
£800k | Early VC | ||
£910k | Early VC | ||
N/A | Merger | ||
| Total Funding | €4.5m | ||
Recent News about Censo Biotechnologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
